Suven Life Sciences Ltd share price logo

Suven Share Price

NSE: SUVEN

BSE: 530239

Small Cap

Healthcare Sector

₹209.41

+5.52

(+2.71%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Suven Stock Performance

as on October 10, 2025 at 4:01 pm IST

  • Day's Low

    Day's High

    ₹203.3
    ₹216.79
    downward going graph

    2.92%

    Downside

    3.52%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹102.5
    ₹299.99
    downward going graph

    51.05%

    Downside

    43.25%

    Upside

    downward going graph

Suven share price movements today

Previous Close
₹203.89
Open
₹205.80
Volume
3.24L
Upper Circuit
₹224.27
Lower Circuit
₹183.50
Day's Low - High
₹203.3 - ₹216.79
52 Week Low - High
₹102.5 - ₹299.99

Suven Historical Returns

1 Month Return
-5.41 %
3 Month Return
-24.3 %
1 Year Return
+ 49.22 %
3 Year Return
+ 223.11 %
5 Year Return
+ 319.24 %

Suven Fundamentals

as on October 10, 2025 at 4:01 pm IST

Market Cap

₹4,763.54 Cr

Return on Equity (ROE)

-6.33

PE Ratio (TTM)

-24.81

Return on capital employed (ROCE)

-6.3

Industry PE ratio

52.24

Beta (LTM)

1.02

P/B Ratio

3.09

Dividend Yield

0

PEG Ratio

7.23

Quarterly Earnings Growth YOY

83.74

EPS (TTM)

-7.37

Sector

Healthcare

Book Value

5.04

Technical Analysis

Bearish

View Technical Analysis

Suven Stock Valuation

as on October 10, 2025 at 4:01 pm IST

Suven in the last 5 years

  • Overview

  • Trends

Lowest (-165.11x)

February 27, 2020

Today (-24.81x)

October 10, 2025

Industry (52.24x)

October 10, 2025

Highest (-6.67x)

March 27, 2023

LowHigh

Today’s Price to Earnings Ratio: -24.81x

Suven Life Sciences Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Suven with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Suven Life Sciences Ltd image
Suven Life Sciences Ltd
NA4,763.5463.85%0.51-1616
Shalby Ltd image
Shalby Ltd
NA2,722.3930.51%0.6711,086
Deccan Health Care Ltd image
Deccan Health Care Ltd
NA38.46-11.85%0.51175
Dr Agarwals Health Care Ltd image
Dr Agarwals Health Care Ltd
BUY16,920.806.65%0.721101,711
Amkay Products Ltd image
Amkay Products Ltd
NA38.95-11.8%0.00338
See all

Suven Stock’s Investor Sentiment and Interest

Search interest for Suven Life Sciences Ltd Stock has decreased by -38% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-38% versus previous 30 day period

Suven Life Sciences Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sales
3
2.61
3.8
3.06
2.45
2.39
1.01
2.57
1.61
1.47
1.87
Other Income
2.2
5.6
5.64
12.6
6.07
4.28
4.01
4.04
1.63
1.22
0.6
Total Income
5.21
8.21
9.44
15.66
8.52
6.67
5.01
6.61
3.24
2.69
2.47
Expenses
54.59
34.13
31.81
26.57
48.64
32.67
31.54
54.78
40.82
45.29
52.62
Operating Profit
-51.59
-31.52
-28.01
-23.51
-46.19
-30.28
-30.53
-52.21
-39.21
-43.82
-50.75
Operating Profit Margin %
-1719.67%
-1207.66%
-737.11%
-768.3%
-1885.31%
-1266.95%
-3022.77%
-2031.52%
-2435.4%
-2980.95%
-2713.9%
Profit Before Interest, Tax and Depreciation
-49.38
-25.92
-22.37
-10.91
-40.13
-26
-26.53
-48.17
-37.58
-42.6
-50.15
Interest
0.06
0.05
0.05
0.04
0.04
0.03
0.02
0.02
0.01
-
-
Depreciation
1.67
1.67
1.66
1.73
1.6
1.51
1.49
1.46
1.53
1.35
1.37
Profit Before Tax
-51.11
-27.64
-24.08
-12.68
-41.77
-27.54
-28.04
-49.65
-39.12
-43.95
-51.52
Tax Paid
-
-
-
-
-
-1
-
-
-
-
-
Profit After Tax
-51.12
-27.64
-24.09
-12.68
-41.76
-26.54
-28.04
-49.64
-39.12
-43.94
-51.52
Total Net profit including share of profit / Loss from associate company
-51.12
-27.64
-24.09
-12.68
-41.76
-26.54
-28.04
-49.64
-39.12
-43.94
-51.52
EPS
-2.9
-1.17
-1.1
-0.58
-1.92
-1.22
-1.29
-2.27
-1.79
-2.02
-2.36
Actual EPS
-2.9
-1.17
-1.1
-0.58
-1.92
-1.22
-1.29
-2.27
-1.79
-2.02
-2.36
Adjusted EPS
-2.9
-1.17
-1.1
-0.58
-1.92
-1.22
-1.29
-2.27
-1.79
-2.02
-2.36
Diluted EPS
-2.9
-1.17
-1.1
-0.58
-1.92
-1.22
-1.29
-2.27
-1.79
-2.02
-2.36

Suven Life Sciences Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
539.17
625.26
285.67
14.41
13.48
11.84
13.54
11.69
6.66
Other Income
21.09
23.27
27.25
14.04
7.75
5.32
14.45
28.59
10.9
Total Income
565.57
648.53
312.91
28.45
21.23
17.16
27.99
40.28
17.55
Expenses
415.4
427.07
300.06
130.2
93.54
134.23
139.42
139.7
172.43
Operating Profit
123.77
198.19
-14.39
-115.79
-80.06
-122.39
-125.88
-128.01
-165.77
Operating Profit Margin %
22.96%
31.7%
-5.04%
-803.54%
-593.92%
-1033.7%
-929.69%
-1095.04%
-2489.04%
Profit Before Interest, Tax and Depreciation
150.17
221.46
12.86
-101.75
-72.31
-117.07
-111.44
-99.42
-154.88
Interest
5.68
4.63
1.91
0.49
0.82
0.53
0.29
0.16
0.05
Depreciation
21.41
21.31
10.79
4.17
4.35
4.39
6.54
6.5
5.82
Profit Before Tax
123.08
195.52
0.16
-106.41
-77.48
-121.99
-118.27
-106.08
-160.75
Tax Paid
35.88
71.83
24.06
-12.18
-5.32
-
-
-1
-
Profit After Tax
87.19
123.69
-23.9
-94.22
-72.15
-122
-118.27
-105.08
-160.75
Total Net profit including share of profit / Loss from associate company
87.19
123.69
-23.9
-94.22
-72.15
-122
-118.27
-105.08
-160.75
EPS
6.84
9.72
-1.88
-7.4
-5.67
-9.05
-6.63
-4.82
-7.37
Actual EPS
6.84
9.72
-1.88
-7.4
-5.67
-9.05
-6.63
-4.82
-7.37
Adjusted EPS
0.32
0.45
-0.09
-6.82
-5.22
-8.34
-6.63
-4.82
-7.37
Diluted EPS
6.84
9.72
-1.88
-7.4
-5.67
-9.05
-6.63
-4.82
-7.37

Suven Life Sciences Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
67.5
109.17
69.94
-52.61
-134.57
-96.02
-127.54
-115.98
-115.47
-154.1
Cash Flow from Investing Activities
-38.63
-310.64
-0.61
30.43
146.21
55.85
-22.22
-247.81
94.44
154.95
Cash Flow from Financing Activities
-68.07
-30.39
-52.07
4.54
2.8
34.85
145.69
395.54
-1.06
-0.76
Net Cash Flow
-39.2
-231.86
17.26
-17.66
14.45
-5.33
-4.07
31.75
-22.09
0.09

Suven Stock Shareholding Pattern

Numbers in percentages

Nov 2022
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Jul 2025
Promoters
64.98%
69.57%
69.57%
69.57%
69.57%
69.57%
69.57%
70.27%
70.27%
70.27%
70.27%
70.27%
67.43%
DII
0.12%
0.11%
0.11%
0.08%
0.01%
0.12%
1.17%
1.17%
1.05%
1.06%
0.01%
0.02%
3.41%
FII
0%
0%
0%
0%
0.5%
0.54%
0.46%
0.45%
0.34%
0.34%
0.25%
0.59%
0.56%
Public
34.42%
29.87%
29.81%
29.88%
29.93%
29.77%
28.81%
28.12%
28.34%
28.34%
29.47%
29.12%
28.61%
Total Outstanding Shares
14,53,82,478
21,80,73,717
21,80,73,717
21,80,73,717
21,80,73,717
21,80,73,717
21,80,73,717
21,80,73,717
21,80,73,717
21,80,73,717
21,80,73,717
21,80,73,717
22,72,60,207
Total Shareholders
80,536
80,838
78,634
76,291
80,953
74,003
68,959
66,116
63,975
63,537
64,603
66,159
65,574

Mutual Funds that own Suven Stock

Check out the Mutual Funds with significant holdings in Suven.

Suven Corporate Actions

View detailed summary of the earnings and dividend history of Suven.

  • Suven Life Sciences Ltd Earnings Results

    Suven Life Sciences Ltd’s net profit fell -83.74% since last year same period to ₹-51.52Cr in the Q1 2025-2026. On a quarterly growth basis, Suven Life Sciences Ltd has generated -17.25% fall in its net profits since last 3-months.

    Read More about Earnings Results

  • Suven Life Sciences Ltd Dividends February,2019

    In the quarter ending December 2018, Suven Life Sciences Ltd has declared dividend of ₹1.50 per share on 05 Feb 2019 - translating a dividend yield of 0.72%.

    Read More about Dividends

Indices Featuring Suven Stock

Check stock indices that include Suven.

BSE Healthcare

₹44,688.17

0.99 (▲436.24%)

BSE Small-Cap

₹53,378.57

0.59 (▲314.14%)

Insights on Suven Life Sciences Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 0.01% to 2.08% in Jul 2025 quarter

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, SUVEN has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, SUVEN has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 29.12% to 28.61% in Jul 2025 quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 4 quarters, 6.61 Cr → 2.47 Cr (in ₹), with an average decrease of 25.4% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, -39.12 Cr → -51.52 Cr (in ₹), with an average decrease of 14.8% per quarter

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 70.27% to 67.43% in Jul 2025 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 months, SUVEN stock has moved down by -24.3%

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 0.59% to 0.56% in Jul 2025 quarter

About Suven Life Sciences Ltd

Suven Life Sciences Limited (erstwhile Suven Pharmaceuticals), established in 1989, is in the business of Contract Research and Manufacturing Services (CRAMS), providing process research and rapid response pilots scale 16 manufacture, custom synthesis, process R&D, and contract manufacturing of intermediates, APIs and formulations. It has two international wholly owned subsidiaries and one Indian wholly owned subsidiary. With the aim of expanding its drug discovery portfolio, a remarkable growth of 71% in total sales and a 325% growth in profit after tax (PAT) was registered during 2000-01. In addition, the company also acquired a pilot plant and got its recertification of ISO 9002 during the same year. In 2013-14, Suven granted an exclusive license to Taro Pharmaceuticals to market its product Head Lice Lotion in the US, Canada and Mexico, estimated at US$35million. During FY2014-15, one of its lead clinical candidates SUVN 502 has successfully completed the Phase 1b clinical trial, leading way for the entry into Proof of Concept (PoC) Phase 2a study. Thesaid year also saw the Company issuing and alloting 10, 453, 690 equity shares of Re 1/ each at a premium of Rs190.32 per share by way of QIP issue. In 2018-19, a Scheme of Arrangement for Demerger was initiated between Suven Life Sciences and Suven Pharmaceuticals Limited, resulting in a mirror shareholding of Suven Life Sciences in Suven Pharmaceuticals Limited. Consequently, Suven Pharmaceuticals Ltd., India and Suven Pharma Inc., USA became subsidiary companies of the group. As of 31st March 2019, investments were made to Suven Neurosciences Inc., a wholly owned subsidiary, amounting to Rs. 13, 636 lakh and no investments were made into newly formed Suven Pharma Inc., USA.

Revenue: ₹1.87Cr as on June 2025 (Q1 FY26)
Net Profit: ₹-51.52Cr as on June 2025 (Q1 FY26)
Listing date: 23 Oct, 2003
Chairperson Name: Venkateswarlu Jasti
OrganisationSuven Life Sciences Ltd
HeadquartersHyderabad
IndustryHealthcare
CEOVenkateswarlu Jasti
E-voting on sharesClick here to vote

FAQs

What is Suven share price today?

Suven share price today stands at ₹209.41 as on at the close of the market. Suven share today touched a day high of ₹216.79 and a low of ₹203.3.

What is the 52 week high and 52 week low range for Suven share?

Suven touched a 52 week high of ₹299.99 and a 52 week low of ₹102.5. Suven share price today i.e. is closed at ₹209.41, which is -30.19% down from its 52 week high and 104.30% up from its 52 week low.

What is Suven's market capitalisation today?

Suven market capitalisation is ₹4,763.54 Cr as on .

How to buy Suven shares?

To buy Suven shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for SUVEN or Suven Life Sciences Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Suven shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Suven trading volume today?

Suven trading volume is 3.24L as on . This means that 3.24L shares of Suven were bought and sold on the stock market during today's trading session.